ENDO 2026 Study Finds Most People Who Stop Ozempic or Tirzepatide for Type 2 Diabetes Eventually Restart Treatment

Medical Daily·Jun 23

This story is reported by Medical Daily. Read what other outlets are saying below, then open the original report for full details.